Merck & Co. Inc. buy Barclays PLC
Start price
23.01.24
/
50%
€108.20
Target price
23.01.25
€124.16
Performance (%)
8.71%
Price
24.07.24
€116.20
Summary
This prediction is currently active. With a performance of 8.71%, the BUY prediction by Barclays_PLC for Merck & Co. Inc. is trending in the right direction. Dividends of €1.42 are taken into consideration when calculating the performance. This prediction currently runs until 23.01.25. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Merck & Co. Inc. | 0.868% | 0.868% |
iShares Core DAX® | -0.612% | 0.567% |
iShares Nasdaq 100 | -3.018% | -3.205% |
iShares Nikkei 225® | -2.647% | 0.330% |
iShares S&P 500 | -1.932% | -1.126% |
Comments by Barclays_PLC for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) had its price target raised by analysts at Barclays PLC from $130.00 to $135.00. They now have an "overweight" rating on the stock.
Ratings data for MRK provided by MarketBeat
Stopped prediction by Barclays_PLC for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€116.60
02.02.24
02.02.24
€134.11
02.02.25
02.02.25
0.88%
24.07.24
24.07.24